FDA Approves LimFlow System in Patients with Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revasucularization Options by Seini Moimoi | Sep 12, 2023 | Portfolio News
Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as Chief Financial Officer by Seini Moimoi | Sep 11, 2023 | Portfolio News
CG Oncology Announces Key Executive Appointments in Commercialization, Medical and Manufacturing Operations by Seini Moimoi | Sep 5, 2023 | Portfolio News
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics by Seini Moimoi | Sep 5, 2023 | Portfolio News
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb by Seini Moimoi | Sep 5, 2023 | Portfolio News
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline by Seini Moimoi | Aug 2, 2023 | Portfolio News
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Advance Clinical-Stage Bladder Cancer Pipeline by Seini Moimoi | Aug 2, 2023 | Uncategorized
Lexeo Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy by Seini Moimoi | Aug 1, 2023 | Portfolio News
CG Oncology Completes Patient Enrollment in BOND-003 Phase 3 Monotherapy Study with Cretostimogene Grenadenorepvec in BCG-Unresponsive High-Risk NMIBC by Seini Moimoi | Jul 24, 2023 | Portfolio News
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) by Seini Moimoi | Jul 10, 2023 | Portfolio News
